CORC

浏览/检索结果: 共14条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Efficacy and safety of rh-endostatin (Endostar) combined with pemetrexed/cisplatin followed by rh-endostatin plus pemetrexed maintenance in non-small cell lung cancer: A retrospective comparison with standard chemotherapy 期刊论文
2018, 卷号: 9, 期号: 11, 页码: 1354-1360
作者:  Zhou, Shengyu;  Zuo, Lijie;  He, Xiaohui;  Pi, Jinping;  Jin, Jun
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/03
A Multicenter, Open-Label, Randomized Phase II Controlled Study of rh-Endostatin (Endostar) in Combination with Chemotherapy in Previously Untreated Extensive-Stage Small-Cell Lung Cancer 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2015, 卷号: 10, 期号: 1
作者:  Lu, Shun;  Li, Lu;  Luo, Yi;  Zhang, Li;  Wu, Gang
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
A Multicenter, Open-Label, Randomized Phase II Controlled Study of rh-Endostatin (Endostar) in Combination with Chemotherapy in Previously Untreated Extensive-Stage Small-Cell Lung Cancer 期刊论文
Journal of Thoracic Oncology, 2015, 卷号: 10, 期号: 1, 页码: 206-211
作者:  Lu, Shun*;  Li, Lu;  Luo, Yi;  Zhang, Li;  Wu, Gang
收藏  |  浏览/下载:8/0  |  提交时间:2019/12/03
Salvage Therapy of Gemcitabine Plus Endostar Significantly Improves Progression-free Survival (PFS) with Platinum-resistant Recurrent Epithelial Ovarian Cancer 期刊论文
http://dx.doi.org/10.7314/APJCP.2013.14.3.1841, 2013
Su, An; Zhang, Jing; Pan, Zhan-He; Zhou, Qi-Ming; Lv, Xia; 张靖
收藏  |  浏览/下载:4/0  |  提交时间:2015/07/22
Dynamic Contrast-Enhanced MR Imaging in a Phase Study on Neoadjuvant Chemotherapy Combining Rh-Endostatin with Docetaxel and Epirubicin for Locally Advanced Breast Cancer 期刊论文
http://dx.doi.org/10.7150/ijms.5123, 2013
Jia, Qianxin; Xu, Junqing; Jiang, Weifeng; Zheng, Minwen; Wei, Mengqi; Chen, Jianghao; Wang, Ling; Huan, Yi; 郏潜新
收藏  |  浏览/下载:5/0  |  提交时间:2015/07/22
Long-term results of a randomized, double-blind, and placebo-controlled phase III trial: Endostar (rh-endostatin) versus placebo in combination with vinorelbine and cisplatin in advanced non-small cell lung cancer 期刊论文
Thoracic cancer, 2013, 卷号: 4, 期号: 4, 页码: 440-448
作者:  Sun,Y.;  Wang,J.W.;  Liu,Y.Y.;  Yu,Q.T.;  Zhang,Y.P.
收藏  |  浏览/下载:9/0  |  提交时间:2019/12/23
Long-term results of a randomized, double-blind, and placebo-controlled phase III trial: Endostar (rh-endostatin) versus placebo in combination with vinorelbine and cisplatin in advanced non-small cell lung cancer 期刊论文
2013, 卷号: 4, 期号: 4, 页码: 440-448
作者:  Sun, Yan;  Wang, Jin Wan;  Liu, Yong Yu;  Yu, Qi Tao;  Zhang, Yi Ping
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/13
Randomized, double-blind, and multicenter phase II trial of rh-endostatin plus dacarbazine versus dacarbazine alone as first-line therapy for the patients with advanced melanoma. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2012, 卷号: 30, 期号: 15
作者:  Guo, Jun;  Cui, Chuan Liang;  Gu, Kangsheng;  Tao, Min;  Xin, Song
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/04
Randomized, double-blind, and multicenter phase II trial of rh-endostatin plus dacarbazine versus dacarbazine alone as first-line therapy for the patients with advanced melanoma 期刊论文
Journal of Clinical Oncology, 2012, 卷号: 30
作者:  Guo J., Cui C.L., Gu K., Tao M., Xin S., Lin T., Ren X.B., Qin S.
收藏  |  浏览/下载:8/0  |  提交时间:2019/12/04
Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer 期刊论文
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2012, 卷号: 10, 期号: [db:dc_citation_issue]
作者:  Rong Biaoxue;  Yang Shuanying;  Li Wei;  Zhang Wei;  Ming Zongjuan
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/10


©版权所有 ©2017 CSpace - Powered by CSpace